Ortiz, Ana P.
Torres-Cintrón, Carlos R.
Santiago-Rodríguez, Eduardo J.
Ramos-Cartagena, Jeslie M.
Suárez-Ramos, Tonatiuh
Damgacioglu, Haluk
Colón-López, Vivian
Ortiz-Ortiz, Karen J.
Deshmukh, Ashish A.
Article History
Received: 21 March 2024
Accepted: 18 July 2024
First Online: 13 August 2024
Declarations
:
: The University of Puerto Rico Comprehensive Cancer Center Institutional Review Board considered this study exempt (number: 2019–09-11).
: Not applicable.
: Dr. Deshmukh reported receiving consulting fees from Merck Inc and Value Analytics Lab outside the submitted work. Dr. Ortiz has been a consultant for Merck Inc and participates in an institutional grant funded by Merck Inc outside the submitted work. No additional competing interests were reported by the rest of the authors.